Cargando…

Validation of Friedewald, Martin-Hopkins and Sampson low-density lipoprotein cholesterol equations

BACKGROUND: Low-density lipoprotein cholesterol (LDL-C) is an important biomarker for determining cardiovascular risk and regulating lipid lowering therapy. Therefore, the accurate estimation of LDL-C concentration is essential in cardiovascular disease diagnosis and prognosis. Sampson recently prop...

Descripción completa

Detalles Bibliográficos
Autores principales: Ertürk Zararsız, Gözde, Bolat, Serkan, Cephe, Ahu, Kochan, Necla, Yerlitaş, Serra İlayda, Doğan, Halef Okan, Zararsız, Gökmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106156/
https://www.ncbi.nlm.nih.gov/pubmed/35559957
http://dx.doi.org/10.1371/journal.pone.0263860
_version_ 1784708215039066112
author Ertürk Zararsız, Gözde
Bolat, Serkan
Cephe, Ahu
Kochan, Necla
Yerlitaş, Serra İlayda
Doğan, Halef Okan
Zararsız, Gökmen
author_facet Ertürk Zararsız, Gözde
Bolat, Serkan
Cephe, Ahu
Kochan, Necla
Yerlitaş, Serra İlayda
Doğan, Halef Okan
Zararsız, Gökmen
author_sort Ertürk Zararsız, Gözde
collection PubMed
description BACKGROUND: Low-density lipoprotein cholesterol (LDL-C) is an important biomarker for determining cardiovascular risk and regulating lipid lowering therapy. Therefore, the accurate estimation of LDL-C concentration is essential in cardiovascular disease diagnosis and prognosis. Sampson recently proposed a new formula for the estimation of LDL-C. However, little is known regarding the validation of this formula. OBJECTIVES: This study aimed to validate this new formula with other well-known formulas in Turkish population, composed of adults. METHODS: A total of 88,943 participants above 18 years old at Sivas Cumhuriyet University Hospital (Sivas, Turkey) were included to this study. LDL-C was directly measured by homogeneous assays, i.e., Roche, Beckman and Siemens and estimated by Friedewald’s, Martin-Hopkins’, extended Martin-Hopkins’ and Sampson’s formulas. The concordances between the estimations obtained by the formulas and the direct measurements were evaluated both in general and separately for the LDL-C, TG and non-HDL-C sublevels. Linear regression analysis was applied and residual error plots were generated between each estimation and direct measurement method. Coefficient of determination (R(2)) and mean absolute deviations were also calculated. RESULTS: The results showed that the extended Martin-Hopkins approach provided the most concordant results with the direct assays for LDL-C estimation. The results also showed that the highest concordances were obtained between the direct assays with the extended Martin-Hopkins formula calculated with the median statistics obtained from our own population. On the other hand, it was observed that the results of the methods may differ in different assays. The extended Martin-Hopkins approach, calculated from the median statistics of our population, gave the most concordant results in patients with “low LDL-C level (LDL-C levels < 70 mg/dL) or hypertriglyceridemia (TG levels ≥ 400 mg/dL)”. CONCLUSIONS: Although the results of the formulas in different assays may vary, the extended Martin-Hopkins approach was the best one with the highest overall concordances. The validity of the Martin Hopkins’ and Sampson’s formulas has to be further investigated in different populations.
format Online
Article
Text
id pubmed-9106156
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-91061562022-05-14 Validation of Friedewald, Martin-Hopkins and Sampson low-density lipoprotein cholesterol equations Ertürk Zararsız, Gözde Bolat, Serkan Cephe, Ahu Kochan, Necla Yerlitaş, Serra İlayda Doğan, Halef Okan Zararsız, Gökmen PLoS One Research Article BACKGROUND: Low-density lipoprotein cholesterol (LDL-C) is an important biomarker for determining cardiovascular risk and regulating lipid lowering therapy. Therefore, the accurate estimation of LDL-C concentration is essential in cardiovascular disease diagnosis and prognosis. Sampson recently proposed a new formula for the estimation of LDL-C. However, little is known regarding the validation of this formula. OBJECTIVES: This study aimed to validate this new formula with other well-known formulas in Turkish population, composed of adults. METHODS: A total of 88,943 participants above 18 years old at Sivas Cumhuriyet University Hospital (Sivas, Turkey) were included to this study. LDL-C was directly measured by homogeneous assays, i.e., Roche, Beckman and Siemens and estimated by Friedewald’s, Martin-Hopkins’, extended Martin-Hopkins’ and Sampson’s formulas. The concordances between the estimations obtained by the formulas and the direct measurements were evaluated both in general and separately for the LDL-C, TG and non-HDL-C sublevels. Linear regression analysis was applied and residual error plots were generated between each estimation and direct measurement method. Coefficient of determination (R(2)) and mean absolute deviations were also calculated. RESULTS: The results showed that the extended Martin-Hopkins approach provided the most concordant results with the direct assays for LDL-C estimation. The results also showed that the highest concordances were obtained between the direct assays with the extended Martin-Hopkins formula calculated with the median statistics obtained from our own population. On the other hand, it was observed that the results of the methods may differ in different assays. The extended Martin-Hopkins approach, calculated from the median statistics of our population, gave the most concordant results in patients with “low LDL-C level (LDL-C levels < 70 mg/dL) or hypertriglyceridemia (TG levels ≥ 400 mg/dL)”. CONCLUSIONS: Although the results of the formulas in different assays may vary, the extended Martin-Hopkins approach was the best one with the highest overall concordances. The validity of the Martin Hopkins’ and Sampson’s formulas has to be further investigated in different populations. Public Library of Science 2022-05-13 /pmc/articles/PMC9106156/ /pubmed/35559957 http://dx.doi.org/10.1371/journal.pone.0263860 Text en © 2022 Ertürk Zararsız et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Ertürk Zararsız, Gözde
Bolat, Serkan
Cephe, Ahu
Kochan, Necla
Yerlitaş, Serra İlayda
Doğan, Halef Okan
Zararsız, Gökmen
Validation of Friedewald, Martin-Hopkins and Sampson low-density lipoprotein cholesterol equations
title Validation of Friedewald, Martin-Hopkins and Sampson low-density lipoprotein cholesterol equations
title_full Validation of Friedewald, Martin-Hopkins and Sampson low-density lipoprotein cholesterol equations
title_fullStr Validation of Friedewald, Martin-Hopkins and Sampson low-density lipoprotein cholesterol equations
title_full_unstemmed Validation of Friedewald, Martin-Hopkins and Sampson low-density lipoprotein cholesterol equations
title_short Validation of Friedewald, Martin-Hopkins and Sampson low-density lipoprotein cholesterol equations
title_sort validation of friedewald, martin-hopkins and sampson low-density lipoprotein cholesterol equations
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106156/
https://www.ncbi.nlm.nih.gov/pubmed/35559957
http://dx.doi.org/10.1371/journal.pone.0263860
work_keys_str_mv AT erturkzararsızgozde validationoffriedewaldmartinhopkinsandsampsonlowdensitylipoproteincholesterolequations
AT bolatserkan validationoffriedewaldmartinhopkinsandsampsonlowdensitylipoproteincholesterolequations
AT cepheahu validationoffriedewaldmartinhopkinsandsampsonlowdensitylipoproteincholesterolequations
AT kochannecla validationoffriedewaldmartinhopkinsandsampsonlowdensitylipoproteincholesterolequations
AT yerlitasserrailayda validationoffriedewaldmartinhopkinsandsampsonlowdensitylipoproteincholesterolequations
AT doganhalefokan validationoffriedewaldmartinhopkinsandsampsonlowdensitylipoproteincholesterolequations
AT zararsızgokmen validationoffriedewaldmartinhopkinsandsampsonlowdensitylipoproteincholesterolequations